US industry executives prefer perks to stocks
This article was originally published in Clinica
The chief executive officers of publicly-traded medical device companies in the US earned an average of $403,400 in 1997. An as yet unpublished executive compensation survey by the accountancy firm, PricewaterhouseCoopers, says this salary level ranks in the mid-point range for the life science industries.
You may also be interested in...
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.